Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 12:53 AM
NCT ID:
NCT02582567
Eligibility Criteria:
Inclusion criteria:
* Overweight pregnant woman with a normal pregnancy course.
* Answer "no" to all questions on the PARmed-X for pregnancy\*.
* To be able to walk without assistance.
* To be able to read and write enough.
* Informed consent: To be capable and willing to provide consent. \*In addition, specific inclusion criteria for data analysis are: gestational age at delivery of 37-42 weeks with single foetus, spontaneous vaginal delivery or instrumental vaginal and caesarean without maternofoetal pathology (or other indication that does not involve maternofoetal risk, such as disproportion, failed induction, no foetal progression or non-cephalic presentation), newborn with appropriate weight, Apgar score\>7 in the 1st and 5th minute of life, cord blood pH (normal\>7.20) and normal monitoring results.
Exclusion criteria:
* Acute or terminal illness.
* Malnutrition.
* Inability to conduct tests for assessing physical fitness or exercise during pregnancy.
* Underweight, normal-weight or obesity.
* Pregnancy risk factors (such as hypertension, type 2 diabetes, etc.).
* Multiple pregnancies.
* Chromosopathy or foetal malformations.
* Uterine growth restriction.
* Foetal death.
* Upper or lower extremity fracture in the past 3 months.
* Presence of neuromuscular disease or drugs affecting neuromuscular function
* Be registered in other exercise program
* Perform more than 300 minutes of at least moderate physical activity per week
* Unwillingness to either complete the study requirements or to be randomised into control or intervention group.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
25 Years
Maximum Age:
40 Years
Study:
NCT02582567
Study Brief:
Protocol Section:
NCT02582567